Related Experiment Video
Updated: Nov 3, 2025
09:56
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
936
Thymic Carcinomas and Second Malignancies: A Single-Center Review
Sunil S Badve1, Rachel Dougherty1, Michael Balatico1
1Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Cancers
|June 2, 2021
Summary
Patients with thymic carcinoma have a high incidence of second malignancies, similar to thymomas. This suggests potential immune system dysfunction may contribute to the development of these secondary cancers.
Area of Science:
- Oncology
- Immunology
Background:
- Thymic carcinomas are rare and aggressive cancers.
- Autoimmune disorders are linked to thymic tumors.
- Second malignancies are known complications of thymomas.
Purpose of the Study:
- To determine the incidence of second malignancies in patients diagnosed with thymic carcinoma.
Main Methods:
- Retrospective review of 92 thymic carcinoma cases from pathology archives.
- Correlation of histological findings with clinical data for 85 patients.
- Identification and cataloging of all diagnosed second cancers.
Main Results:
- 16.5% of patients (14 out of 85) with thymic carcinoma developed a second malignancy.
- Diagnosed second cancers included lung, testicular, breast, prostate, lymphoma, thyroid, bladder, kidney, and melanoma.
- The incidence of second cancers in thymic carcinoma patients mirrors that observed in thymoma patients.
Conclusions:
- Thymic carcinoma patients exhibit a significant rate of second malignancies.
- The high incidence suggests a potential role for impaired immunological surveillance in thymic tumors.
- Further research into immune mechanisms is warranted.
